Information About Covidien Hernia Mesh Complications Provided on Plaintiff Fact Sheets

Plaintiff Fact Sheets will be completed in each of the bellwether cases, which have been selected for early trials over Covidien hernia mesh complications.

The U.S. District Judge presiding over all federal hernia mesh lawsuits filed over Covidien products has approved the use of a standardized Plaintiff Fact Sheet, which is designed to gather information about the complications experienced by each individual now pursuing a claim against the mesh manufacturer.

Medtronic and its Covidien subsidiary currently hundreds of product liability lawsuits brought in the federal court system, each involving similar allegations that plaintiffs experienced painful complications after receiving defective polypropylene hernia mesh products sold in recent years, including Covidien Parietex, Covidien Symbotex and others.

Plaintiffs report that a defective mesh design caused them to experience severe abdominal pain, infections, organ perforations, erosion and other problems, often resulting in the need for a risky hernia revision surgery to remove the Covidien mesh from their bodies.

Hernia Mesh Lawsuits

Did you or a loved one receive a hernia mesh?

Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery.

Learn More See If You Qualify For Compensation

Given common questions of fact and law raised in complaints filed in U.S. District Courts nationwide, the U.S. Judicial Panel on Multidistrict Litigation decided to centralize the Covidien hernia mesh lawsuits in June 2022, transferring all cases to U.S. District Judge Patti B. Saris in the District Judge in Massachusetts, for coordinated discovery and a series of early trial dates.

Judge Saris has put a plan in place to select a representative group of Covidien hernia mesh lawsuits to serve as “bellwether” early test trials. While the outcomes of these cases will not be binding on other claims, the trials are designed to see how juries are likely to respond to testimony and evidence which could be presented in hundreds, perhaps thousands, of trials if the litigation is not settled or otherwise resolved during the pretrial proceedings.

In February, Judge Saris announced that six cases, including three chosen by plaintiffs and three by defendants, will serve as the bellwether discovery pool. It is from these cases that the first bellwether trials will be selected.

On April 3, Judge Saris issued a case management order (PDF) calling for each bellwether pool claimant to complete a Plaintiff Fact Sheet (PFS), which are commonly used in complex mass tort litigation where large numbers of individuals are pursuing claims against the makers of the same product, involving similar injuries or claims.

The Fact Sheet will gather case-specific information about the Covidien hernia mesh complications experienced by each plaintiff, including the specific products received, treatment dates and relevant background information needed to complete written discovery.

The order indicates the PFS’s were due on April 1, and any new plaintiffs added to the bellwether pool after that date will have 45 days to complete and submit their own Plaintiff Fact Sheet.

Over the coming months, the parties will engage in additional fact discovery, including depositions of plaintiffs, treating physician and other relevant witnesses that may testify at trial. The bellwether process will then move into the expert discovery phase, including any challenges to the admissibility of expert opinion testimony before the first cases are presented to a jury.

April 2023 Covidien Hernia Mesh Lawsuit Update

Thousands of Covidien hernia mesh lawsuits have been filed over problems with Symbotex mesh, Parietex mesh and other similar products constructed of polypropylene, each involving similar allegations that the designs were defective and resulted in painful complications.

Most of the U.S. litigation is currently pending in the state court system of Massachusetts, where Covidien’s U.S. headquarters are located.

At least three other hernia mesh MDLs were previously established for claims involving other polyethylene products sold by different companies, with more than 15,400 Bard hernia mesh lawsuits centralized in the Southern District of Ohio, another 3,600 Ethicon Physiomesh lawsuits centralized in the Northern District of Georgia and 3,251 Atrium C-Qur lawsuits centralized in the District of New Hampshire. Many of those claims settled before the first claims ever went before a jury.

1 Comments

  • TonyAugust 13, 2023 at 6:37 pm

    I Tony Duckworth have had five hernia mesh implants and had a lawsuit back in 2017 til 2021 on the Covidien Mesh that was lost from what l was told but by reading other facts the Covidien Hernia mesh is still in Court so l am asking why was my Lawsuit dismissed and it's still pending in Court l feel l should be entitled to compensation please let me know if l am correct. Thank you so very kindly[Show More]I Tony Duckworth have had five hernia mesh implants and had a lawsuit back in 2017 til 2021 on the Covidien Mesh that was lost from what l was told but by reading other facts the Covidien Hernia mesh is still in Court so l am asking why was my Lawsuit dismissed and it's still pending in Court l feel l should be entitled to compensation please let me know if l am correct. Thank you so very kindly!

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025
MDL Judge Schedules Ozempic Lawsuit Status Conferences Throughout 2025 (Posted today)

With the first Ozempic lawsuit bellwether trials not expected to begin until at least late 2026 or early 2027, the court will address motions to dismiss and other “cross cutting” issues in 2025.